Astellas completes strategic layout and upgrade in China

The multinational pharmaceutical enterprise Astellas has announced an upgrade of its strategic layout in China.

Astellas China Investment Co Ltd and Beijing Astellas Medical Co Ltd have been established, on the basis of the existing Astellas Pharma China Inc, to jointly promote the vigorous development of Astellas in China.

Astellas covers more than 70 countries and regions all over the world, and entered the China market in 1994. The company has been marketing products in many specialized treatment fields such as oncology, transplantation immunity, urinary health and infection.

After upgrading, the new structure consisting of one headquarters and two centers will come into being, and Astellas Investment, as the regional headquarters in China, will play a critical role in the overall layout, strategic decision-making, and resource coordination to support the company's development in all aspects.

Beijing Astellas Medical will be responsible for the sales and marketing of oncology and specialized treatment products in China, and Astellas Pharma will further focus on production and manufacturing.